Manx Care says it's currently experiencing a supply issue with two drugs used in the treatment of strokes and heart conditions.
It says the global supply issue (which could continue for the rest of 2022) is having an effect across all NHS trusts in the UK.
As a result the health board has been advised to conserve supplies of some alteplase and tenecteplase injections.
Dr. Sreeman Andole, Executive Medical Director and Stroke Consultant, has said the board doesn't want to alarm the public and is preserving stocks and using alternatives where it’s clinically safe to do so.
Framework of new Sea Services Agreement ready, says minister
Attorney General says he's stepping down
Road closures in two towns for running event this week
Six weekend ferry crossings could face disruption
President of Tynwald announces retirement
Police close Mountain road
Fuel firm says "fingers crossed" for calmer energy costs
Ring doorbells will need data protection registration - but shouldn't cost you money
